Syndax Pharmaceuticals Inc
Recent Filings
All 629 filings →Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Goldan Keith A. | Chief Financial Officer | Sale | 1,296 @ $9.29 | 92,450 | Jul 16, 2025 |
| Metzger Michael A | Chief Executive Officer | Sale | 7,534 @ $9.29 | 298,661 | Jul 16, 2025 |
| Goldan Keith A. | Chief Financial Officer | Purchase | 3,000 | 93,746 | May 19, 2025 |
| Huber Martin H. Jr. | — | Purchase | 5,000 @ $8.99 | 79,000 | May 19, 2025 |
| Katkin Keith | — | Purchase | 10,000 @ $9.11 | 100,000 | May 19, 2025 |
| Botwood Nicholas A.J. | Head of R&D, CMO | Purchase | 11,765 @ $9.00 | 35,165 | May 16, 2025 |
| Goldan Keith A. | Chief Financial Officer | Sale | 3,777 @ $15.50 | 90,746 | Feb 10, 2025 |
| Metzger Michael A | Chief Executive Officer | Sale | 13,288 @ $15.50 | 300,121 | Feb 10, 2025 |
| Gallagher Neil | President, Head of R&D | Sale | 4,618 @ $15.50 | 85,095 | Feb 10, 2025 |
| Gallagher Neil | President, Head of R&D | Award / Grant | 18,500 | 66,313 | Feb 5, 2025 |